课题基金 / 基金详情

Immune regulation, cellular trafficking and chemokine receptors in intestinal inflammation

Immune regulation, cellular trafficking and chemokine receptors in intestinal inflammation
肠道炎症中的免疫调节、细胞运输和趋化因子受体
批准号:
nhmrc : 222752
负责人:
Prof Andrew Lloyd
金额:
$13.65万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2003
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2003-01-01 至 2005-12-31

项目摘要

项目成果

Prof Andrew Lloyd的其他基金

相似基金

相关文献

中文摘要
翻译
肠道暴露于大量的外来物质或抗原,从食物到肠道中大量的细菌。肠道免疫系统已经开发出复杂的和知之甚少的机制,以防止炎症反应这些抗原。这些控制机制的崩溃可能是导致腹痛、腹泻和出血的慢性肠道疾病(称为炎症性肠病)的部分原因。最近描述的一种免疫细胞类型,称为调节性T细胞(T reg),是一种强大的候选细胞,是肠道炎症的主要控制者。我们知道,T细胞在称为趋化因子的肠样蛋白质的影响下移动到体内的各个部位,但肠中T reg细胞的存在,它们的特征,它们的行为以及它们对趋化因子的特异性反应都是未知的。这些研究旨在检查人类和小鼠肠道中T reg细胞的存在和性质,包括健康和炎症,并探索这些细胞如何在趋化因子的影响下迁移到肠道中。这些知识将有助于我们理解肠道免疫和免疫反应的内源性调节,并将为炎症性肠病和潜在的其他炎症性疾病的治疗提供新的靶点。
英文摘要
The intestine is exposed to a vast array of foreign substances, or antigens, from food to the abundant bacteria that populate the gut. The gut immune system has developed elaborate and poorly understood mechanisms for preventing inflammation in response to these antigens. A breakdown in these control mechanisms may be partly responsible for the chronic intestinal diseases known as inflammatory bowel diseases, which cause abdominal pain, diarrhoea and bleeding. A recently described immune cell type, known as a regulatory T cell (T reg), is a powerful candidate cell as a master controller of intestinal inflammation. We know that T cells move to various sites in the body under the influence of hormone-like proteins known as chemokines, but the existence of T reg cells in the intestine, their characteristics, their behaviour and their specific response to chemokines, are all unknown. These studies aim to examine the presence and nature of T reg cells in human and mouse intestine, in both health and inflammation, and to explore how these cells migrate into the gut under the influence of chemokines. This knowledge will help in our understanding of intestinal immunity and endogenous regulation of immune responses, and will provide new targets for treatment of inflammatory bowel disease, and potentially other inflammatory diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving the health of people with problematic drug use: hepatitis C and drug dependence
  • 批准号:
    nhmrc : 1150078
  • 项目类别:
    Program Grants
  • 资助金额:
    $604.13万
  • 财政年份:
    2019
  • 负责人:
    Prof Andrew Lloyd
  • 依托单位:
Improving the health of people with problematic drug use: hepatitis C and drug dependence
  • 批准号:
    nhmrc : GNT1150078
  • 项目类别:
    Programs
  • 资助金额:
    $906.01万
  • 财政年份:
    2019
  • 负责人:
    Prof Andrew Lloyd
  • 依托单位:
Determinants of the outcomes from infectious diseases
  • 批准号:
    nhmrc : 1137587
  • 项目类别:
    Practitioner Fellowships
  • 资助金额:
    $39.03万
  • 财政年份:
    2018
  • 负责人:
    Prof Andrew Lloyd
  • 依托单位:
Determinants of the outcomes from infectious diseases
  • 批准号:
    nhmrc : GNT1043067
  • 项目类别:
    Practitioner Fellowships
  • 资助金额:
    $35.52万
  • 财政年份:
    2013
  • 负责人:
    Prof Andrew Lloyd
  • 依托单位:
国内基金
海外基金
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵福军
  • 依托单位:
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
  • 批准号:
    82371651
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵栋
  • 依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
  • 批准号:
    82370798
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    王晓
  • 依托单位:
精氨酸调控骨髓Tregs稳态在脓毒症骨髓功能障碍中的作用研究
  • 批准号:
    82371770
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    宁铂涛
  • 依托单位: